Pages that link to "Q46295477"

The following pages link to A combined cell therapy and in-situ tissue-engineering approach for myocardial repair (Q46295477):

Displaying 32 items.

• Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves survival and differentiation of transplanted mesoangioblasts in acute and chronic skeletal-muscle degeneration. (Q22001191) (← links)
• Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes (Q24623082) (← links)
• ECM and ECM-like materials - Biomaterials for applications in regenerative medicine and cancer therapy (Q26776443) (← links)
• Generation and Assessment of Functional Biomaterial Scaffolds for Applications in Cardiovascular Tissue Engineering and Regenerative Medicine (Q30390768) (← links)
• 2D and 3D self-assembling nanofiber hydrogels for cardiomyocyte culture (Q30537357) (← links)
• Multimodal Hydrogel-Based Platform To Deliver and Monitor Cardiac Progenitor/Stem Cell Engraftment. (Q33612426) (← links)
• 3D hydrogel environment rejuvenates aged pericytes for skeletal muscle tissue engineering (Q33687916) (← links)
• Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells. (Q33699342) (← links)
• Pluripotent stem cell derived cardiomyocytes for cardiac repair (Q33875374) (← links)
• Marching towards regenerative cardiac therapy with human pluripotent stem cells (Q34087548) (← links)
• Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming (Q34408109) (← links)
• Making cardiomyocytes with your chemistry set: Small molecule-induced cardiogenesis in somatic cells. (Q35193483) (← links)
• Using bimodal MRI/fluorescence imaging to identify host angiogenic response to implants (Q35549122) (← links)
• Regenerative medicine as applied to general surgery (Q35892487) (← links)
• Injection of Human Cord Blood Cells With Hyaluronan Improves Postinfarction Cardiac Repair in Pigs. (Q36440749) (← links)
• Engineering an in situ crosslinkable hydrogel for enhanced remyelination. (Q36615147) (← links)
• Myoblasts and embryonic stem cells differentially engraft in a mouse model of genetic dilated cardiomyopathy (Q36883829) (← links)
• Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells (Q37542604) (← links)
• Using Biomaterials to Improve the Efficacy of Cell Therapy Following Acute Myocardial Infarction (Q37957060) (← links)
• Embryonic Stem Cells for Severe Heart Failure: Why and How? (Q37992937) (← links)
• Induced pluripotent stem cells for cardiac repair (Q38041929) (← links)
• Biomimetic materials design for cardiac tissue regeneration. (Q38152417) (← links)
• Creating the bioartificial myocardium for cardiac repair: challenges and clinical targets. (Q38161527) (← links)
• Biomaterials in myocardial tissue engineering (Q38234469) (← links)
• Physiologically inspired cardiac scaffolds for tailored in vivo function and heart regeneration (Q38477532) (← links)
• Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering (Q38519839) (← links)
• A comparison of electrospun polymers reveals poly(3-hydroxybutyrate) fiber as a superior scaffold for cardiac repair. (Q39021378) (← links)
• Artificial Cardiac Muscle with or without the Use of Scaffolds. (Q41509582) (← links)
• Real-time tracking of adipose tissue-derived stem cells with injectable scaffolds in the infarcted heart (Q47197395) (← links)
• Tissue engineering (Q85706345) (← links)
• Sustained release of targeted cardiac therapy with a replenishable implanted epicardial reservoir (Q90215636) (← links)
• Injectable Hydrogel-Based Nanocomposites for Cardiovascular Diseases (Q91975793) (← links)